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We tested the hypothesis that rural populations have
increased exposure to Escherichia coli O157:H7. We
measured circulating antibodies against the O157
lipopolysaccharide in rural Wyoming residents and in blood
donors from Casper, Wyoming, and Seattle, Washington,
by enzyme immunoassay (EIA). EIA readings were com-
pared by analysis of variance and the least squares differ-
ence multiple comparison procedure. Rural Wyoming resi-
dents had higher antibody levels to O157 LPS than did
Casper donors, who, in turn, had higher levels than did
Seattle donors (respective least squares means: 0.356,
0.328, and 0.310; p<0.05, Seattle vs. Casper, p<0.001,
rural Wyoming vs. either city). Lower age was significantly
correlated with EIA scores; gender; and, in rural Wyoming,
history of bloody diarrhea, town, duration of residence, and
use of nontreated water at home were not significantly cor-
related. These data suggest that rural populations are more
exposed to E. coli O157:H7 than urban populations. 
E
scherichia coli O157:H7 is an important human
pathogen. This organism can affect humans in a vari-
ety of ways, ranging from asymptomatic carriage (1) to
diarrhea, bloody diarrhea (the most common manifestation
of illness in culture-proven cases), and the postdiarrheal
thrombotic microangiopathy, hemolytic uremic syndrome
(HUS) (2). Infections with E. coli O157:H7 in the Pacific
Northwest of the United States have been endemic (3) and
epidemic (4). Vehicles transmitting this pathogen include
unpasteurized milk and juice (5,6), undercooked beef (7),
drinking water (8), and contact with infected persons (9).
Data from the Centers for Disease Control and
Prevention (CDC) demonstrate higher incidences of E. coli
O157:H7 infections in rural counties in the United States
than in urban (Paul Mead, unpub. data). Worldwide, rural
populations have been postulated to be at greater risk for
exposure to E. coli O157:H7 by virtue of increased expo-
sure to animals or their excreta in Scotland (10,11); dairy
farm visits have been implicated as a source for infection
in Finland (12) and the United States (13); and animal con-
tacts are a risk factor for the development of HUS in
Switzerland (14). Serologic studies from Canada demon-
strated higher frequencies of antibodies to the O157
lipopolysaccharide (LPS) side chain among residents of
rural areas compared to residents of urban areas (15), and
in Wisconsin children, manure and sheep contact were
recently demonstrated to be risk factors for O157 seropos-
itivity (16). Taken together, these data suggest more
intense or more frequent human exposure to E. coli
O157:H7 in nonurban areas.
Populations in the Pacific Northwest and Rocky
Mountain states provide an opportunity to assess the fre-
quency of exposure to E. coli O157:H7 through serologic
studies. Antibodies to the O157 LPS follow natural infec-
tion with E. coli O157:H7 (17) and are believed to be quite
specific (18) because they are rarely found in healthy peo-
ple. Thus, circulating antibodies to the O157 LPS are
potential markers of population exposure to E. coli
O157:H7. We therefore attempted to assess the distribution
of antibodies to this antigen in three different populations,
encompassing a gradient of population density. 
Methods
Study Participants
Participants were selected for inclusion in this study if
they were >16 years of age, weighed >54 kg, and partici-
pated in voluntary cholesterol screening in several rural
western Wyoming towns (population A), or donated blood
to the Wyoming State (population B) or Puget Sound (pop-
ulation C) blood banks, and provided informed consent.
The Institutional Review Boards of the Children’s Hospital
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Population A consisted of 485 residents of Star Valley,
Wyoming. This valley has extensive agricultural land
usage and consists of a series of small towns along U.S.
Highway 89 in Lincoln County in the northwestern part of
the state; town populations range from 100 to 1,200 resi-
dents. One of these towns had an E. coli O157:H7 outbreak
in 1998 (19). During a local health fair conducted in the
towns of Afton, Thayne, and Alpine during May 1999, par-
ticipants donated 5 mL of blood during phlebotomy for
screening to detect hyperlipidemia and answered a ques-
tionnaire regarding age, gender, treated versus nontreated
domestic water supply, history of bloody diarrhea, location
of sampling, and town of residence. 
Population B was composed of 196 blood donors at
United Blood Services (UBS), Casper, Natrona County,
Wyoming. UBS, Wyoming’s only blood bank, obtains
most of its blood from donors residing within Casper, the
second largest municipality in the state (population 49,644
residents [20] in 52.8 km2 [Mike Jun, pers. comm.]). This
site was chosen for study because of its presumed interme-
diate intensity of exposure to agriculture. Volunteers pro-
vided 5 mL of whole blood in a separate tube as part of the
donation. Gender and age data were available for 127
(65%) of the participants.
Population C consisted of 104 blood donors at the
Puget Sound Blood Center, Seattle, Washington, all of
whom resided in urban or suburban Puget Sound munici-
palities (including Seattle and surrounding communities)
and provided an additional 5 mL of blood for research.
This group was presumed to have less agricultural expo-
sure than populations Aor B. Age and gender were record-
ed for all but two donors. Serum specimens from popula-
tions B and C were collected during the spring and summer
of 1999. 
Cattle and human density data for Lincoln, Natrona,
and King Counties are provided in Table 1. These data
demonstrate the rural-to-urban human population density
and cattle-to-human ratios for the populations chosen.
Blood samples were centrifuged within 3 hours of dona-
tion; serum samples were separated from the packed ery-
throcytes and stored at –70°C until assayed. 
Detection of Antibodies to E. coli O157 LPS
E. coli O157:H7 LPS was purified from strain 86-24
(22) by using phenol extraction (23). Purified LPS under-
went electrophoresis in a 12% polyacrylamide sodium
dodecyl sulfate-polyacrylamide gel electrophoresis gel and
then was transferred to a membrane and probed with anti-
bodies to the LPS antigen (24). Serum specimens were
screened for antibodies to the O157 LPS with an enzyme
immunoassay (EIA) (25), modified by CDC. Briefly, in
preliminary experiments, the optimal LPS concentrations
for coating plates and diluting serum samples were deter-
mined by block titration with phosphate-buffered saline
(PBS) (0.01 M, pH 7.2) and a known positive human sam-
ple. Optimal dilutions of 1:20 for serum and 1:160 of the
antigen stock solution (corresponding to 200 µLof a resus-
pended pellet from a 50-mL overnight culture in Luria
broth [26]) were demonstrated (data not shown).
Next, individual wells of an Immulon II plate (Dynex
Technology, Franklin, MA) were coated with diluted anti-
gen (100 µL) and incubated (4°C, overnight) to enable the
target antigen to adhere to the plates. Then, 150 µL of PBS
containing 1% fetal bovine serum and 0.5% nonfat dry
milk (PBS-M-FBS) was placed in each well. The plates
were then incubated in a blocking step (room temperature,
2 hours) to prevent nonspecific antibody adherence to the
plates. Fluid was then removed, and the plates were
washed four times with 0.01 M PBS containing 0.05%
Tween 20 (PBS-T).
Ten microliters of diluted human serum sample was
added to 190 µL of PBS-M-FBS containing 0.05% Tween
20 (PBS-T-M-FBS), placed into wells of the microtiter
plates, and incubated (37°C, 1 h). The fluid was then
removed, and the plates were washed four times with
PBS-T. One hundred microliters of alkaline-phosphatase–
labeled goat antihuman immunoglobulin (Ig) G/IgM/IgA
(heavy and light chain) (Kierkegaard & Perry
Laboratories, Inc., Gaithersburg, MD), diluted 1:10,000 in
PBS-T-M-FBS, was then placed in each well and incubat-
ed (37°C, 1 h). The plates were then washed four times
with PBS-T.
A substrate solution containing 97 mL diethanolamine,
0.2 g sodium azide, 100 mg magnesium chloride-6H2O,
and 800 mL distilled water was adjusted to a pH of 9.8
with 1 M hydrochloric acid. One p-nitrophenyl phosphate
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Table 1. Cattle and human density data for Lincoln and Natrona Counties, Wyoming, and King County, Washington  (sites of donation) 
Characteristics of regions  Population A (Lincoln County)
b  Population B (Natrona County)
b  Population C (King County)
b 
Residents  14,793  66,798  1,741,785 
Cattle  49,736  61,280  32,806 
Cattle/km
2 
Cattle/resident 
4.7 
3.4 
4.4 
0.92 
6.0 
0.019 
Residents/km
2  1.4  4.8  316.3 
aSource: reference 20. 
bSite of collection. tablet (Sigma Chemical Co., St. Louis, MO) was then
added to 5 mL of substrate solution. One hundred micro-
liters of this solution was placed in each well and incubat-
ed (room temperature, 25 min). The reaction was halted by
adding 50 µL of 3 M sodium hydroxide to each well, and
the optical densities of each well were read in a dual wave-
length micro-EIA reader at λ = 405 nm with background
correction at λ = 540 nm (Elx 800, Bio-Tek Instruments,
Winooski, VT). Each serum sample was assayed in dupli-
cate, and the values were averaged.
Serum from a patient with HUS caused by E. coli
O157:H7 and serum from a study participant without
known E. coli O157:H7 infection in population A were
included as duplicates on each plate as positive and nega-
tive controls, respectively, and values were averaged. Each
plate also contained controls without antigen or primary or
secondary antibody. All plates were normalized linearly in
relation to the positive control in the first group of serum
samples tested. 
Analysis
The complete dataset was first studied by analysis of
variance (ANOVA, Proc GLM, SAS Institute, Inc., Cary,
NC) in a model with EIA readings as the dependent vari-
able, gender and town/city as class-independent variables,
and age as a continuous independent variable. Initially, all
interactions were included in the model, but interactions
not contributing significantly to the model were dropped
from subsequent analyses. Multiple comparisons were
analyzed by using the protected Fisher least squares differ-
ences (LSD) test after confirming that the p value of the
model as a whole was <0.05. The data were approximate-
ly normally distributed, as demonstrated by a Wilk-
Shapiro statistic >0.98 (either for the dataset as a whole or
for each region separately, Proc UNIVARIATE, SAS
Institute, Inc.) and by visualization of the residuals plot.
However, as assumptions of normal distribution of the data
are difficult to confirm robustly, the data were also ana-
lyzed after transformation of these values into binary form
with arbitrarily chosen cutpoints at the 80th and 90th per-
centiles of the EIA scores or with the entire range of EIA
scores categorized at 0.05 increments, using stepwise
logistic regression (Proc LOGISTIC, SAS Institute, Inc.)
with the same independent variables as described above
for the ANOVA (27). Statistically, p values <0.05 were
considered significant for comparisons, and p values <0.05
were set as the criterion for entry and for retention into
logistic regression models.
Results
We tested 785 serum samples for antibody reactivity.
The summary statistics for the O157 EIA are portrayed in
the Figure (panel A), and the demographic characteristics
of each population contributing these serum specimens are
provided in Table 1. The average age of the study partici-
pants was significantly younger in populations B and C,
than in population A. The populations did not differ signif-
icantly with respect to gender.
EIA scores were significantly related to both age
(p<0.01) and population (p<0.001) in ANOVA. The effect
of age is illustrated in the Figure (panel B). Age and gen-
der information were not available for 35% of population
B, but the distributions of EIA scores did not differ
between those observations with and without these data,
suggesting that the loss of data did not bias the results. The
same two variables, age and population, also were signifi-
cantly (p<0.05) associated with EIA score in logistic
regression analysis, irrespective of whether the dependent
variable modeled was the 80th percentile (Table 2) or the
90th percentile of the EIA score or increased increment of
the EIA score (data not shown). 
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Figure. Box plot analysis for enzyme immunoassay (EIA) values,
by populations. X axis represents EIA scores for study partici-
pants.Vertical line in each box represents the median for each
population. The left and right borders of each box are the 25th and
75th percentiles of each population, respectively. The extensions
beyond each box represent the lowest and highest values for each
population. Panel A demonstrates the results for each population;
panel B demonstrates the results by age.Within the rural Wyoming group, the data allowed
analysis of O157 LPS EIA values’ association with addi-
tional variables, including the duration of residence in the
area, occurrence of bloody diarrhea, use of a chlorinated
water supply at the residence, and town of residence with-
in Star Valley (Table 3). None of these variables was sig-
nificantly associated with EIA mean values. Residents liv-
ing in the area for <2 years tended to have higher average
EIAvalues (0.380) than those who resided there for longer
periods (2–5 years, 0.346; >5 years, 0.355). 
Discussion
These data suggest that rural residents have greater
exposure to an antigen or antigens that produce antibodies
to the E. coli O157 LPS antigen than do urban residents.
However, we cannot state with certainty that the precipitat-
ing antigen was actually a pathogenic E. coli O157:H7.
Because the O157 LPS antigen can be expressed by non-
pathogenic E. coli (28), Citrobacter freundii (29), and E.
hermanii (30), knowing the nature of the antigen during
the immunizing event in the participants studied is not pos-
sible. Nonetheless, antibodies to the E. coli O157 LPS
antigen plausibly represent exposure to pathogenic E. coli
O157:H7, especially as examples exist of asymptomatic
carriage of E. coli O157:H7 inducing an antibody response
to O157 LPS (1,31). We believe, therefore, that this sero-
logic reactivity likely represents actual exposure to patho-
genic E. coli O157:H7. Also, our assay did not distinguish
the classes of antibodies that were reactive in the EIA, so
we cannot make estimates about the timing of the exposure
based on class of antibody detected. However, IgA, IgG,
and IgM antibodies to the O157 LPS are each ephemeral
after natural symptomatic infections (32). Thus, the anti-
bodies that we detected in this study quite likely represent
recent exposure to the antigen.
The EIA levels were not proportional to cattle density
per land area, a value that was similar in each of the three
study sites. Thus, human exposure to E. coli O157:H7 can-
not be attributed simply to cattle presence within counties.
However, in rural counties, a higher proportion of resi-
dents might be involved in activities that exposed them to
E. coli O157:H7, including animal contact. Our survey
was not designed to measure such exposures within coun-
ties. Indeed, cattle-to-human spatial proximity in Ontario
is a risk factor for infection in a novel application of live-
stock density indicators and disease incidence (33).
Alternatively, rural residents might have a higher frequen-
cy of exposure to wild animals that carry E. coli O157:H7,
such as deer (34), their excreta, or water that has been con-
taminated with their excreta. However, if a link between
any animal source of E. coli O157:H7 and human exposure
to this pathogen is to be further investigated, population
distributions within counties, proximities of humans to
animals and their excreta, and presence of E. coli O157:H7
in the environment will all need to be examined to deter-
mine the modes of contact.
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Table 2. Age, gender, history EIA value distribution in each population study, and median and range of OD for the EIA readings  
  Population A  Population B  Population C 
Characteristics of populations  (N =485)  (N =196)  (N =104) 
Age (y)    
Mean (SD)  57 (15)  45 (12)  45 (12) 
Male: female (not reported)   225:260  56:71 (69)   56:46 (2)  
OD (EIA units)  
Least squares mean   0.356
b  0.328
c  0.310 
Median (range)  0.348 (0.185–1.115)  0.328 (0.149–0.522)  0.312 (0.222–0.441) 
EIA, 80th percentile N+ (%) 
EIA, 90th percentile N+ (%) 
107 (22.0) 
60 (12.4) 
40 (20.4) 
19 (9.7) 
5 (4.8) 
2 (1.9) 
aEIA, enzyme immunoassay; OD, optical density; SD, standard deviation. 
bp<0.001, population A (Star Valley) vs. either Casper or Seattle. 
cp< 0.05, population C (Seattle) vs. population B (Casper). 
Table 3. Age, gender, and enzyme immunoassay (EIA) value distribution in rural Wyoming communities, including the median and  
range of optical densities (OD) for EIA readings 
  Afton  Alpine  Thayne 
Characteristics of populations  (N=253)  (N=84)  (N=148) 
Age (y)  
  Mean (SD)  56 (15)  55 (12)  61 (14) 
  Median (range)  56 (16–92)  56 (20–78)  63 (16–92) 
Male: female   120:133  39:45   66:82  
OD (EIA units) 
  Least squares mean   0.357  0.340  0.359 
  Median (range)  0.349 (0.192–1.115)  0.343 (0.185–0.550)  0.353 (0.230–0.643) 
EIA, 80th percentile N+ (%) 
EIA, 90th percentile N+ (%) 
69 (27.3) 
38 (15.0) 
11 (13.1) 
5 (6.0) 
31 (20.9) 
16 (10.8) Our data differ from results of previous studies in terms
of statistical analysis and also because we included a gra-
dient of population density. Specifically, our principal
analysis did not require assignment of persons to seropos-
itive or seronegative status categories. While some relation
might exist between percentage of persons who are desig-
nated as having reactive or nonreactive status on the basis
of cutoffs and the comparative distribution of serologic
reactivities in populations, we believe that, when examin-
ing continuous variables, a test that compares values as
continuous measurements (such as analysis of variance)
provides more information and is less arbitrary than the
assignment of categorical positives and negatives. We did,
however, also examine proportions above two cutpoints,
and the same trends were noted. For unknown reasons, we
identified higher EIA scores in younger study participants,
whereas in Ontario, IgG antibodies to the O157 LPS were
highest in participants in their fifth decade of life (15).
Comparing our age-related EIA scores to those reported
recently from Wisconsin, where older children had higher
seropositive rates, is not possible because the latter study
focused on a child population and did not evaluate older
Wisconsin residents (16).
We caution against interpreting our data to mean that
rural populations are immune to, and thereby protected
from, E. coli O157:H7 infections. Many study participants
had antibody levels that were probably too low to confer
protection, even if one assumes that antibodies to this anti-
gen protect against infection. In this regard, an E. coli
O157:H7 infection, which almost always induces a brisk
and high-titer humoral immune response to the O157 LPS
antigen, may not confer a permanently protective
response, as evidenced by documentations of recurrent
infections (35,36). However, in a recent E. coli O157:H7
outbreak in the Star Valley, a higher frequency of antibody
levels to the O157 LPS among the resident population was
proposed as the reason for a lower attack rate among resi-
dents than among visitors (19). We also urge against gen-
eralizing the trend observed in this study, which is derived
from the analysis of only three populations, to all rural
populations, without additional, more widespread, studies
because the populations studied might not be representa-
tive. Nonetheless, our data are consistent with the hypoth-
esis that rural residence carries with it a greater risk for
exposure to E. coli O157:H7 than does urban residence. 
In summary, we have identified an age-dependent, gen-
der-independent, risk for probable exposure to E. coli
O157:H7 in persons living in rural communities. This
exposure frequency is plausibly environmental, rather than
foodborne, in origin because food is distributed widely
throughout North America. However, the possibility exists
that particular food consumption practices, such as drink-
ing raw milk in rural communities, as has been noted in the
United Kingdom (37,38), might have been responsible for
this exposure. We also cannot exclude the possibility that
the differences observed relate to the nature of the partici-
pants studied. That is, donors to blood banks might have
different exposures than participants in lipid screenings at
health fairs. Future studies should attempt to identify the
points of exposure to this antigen, confirm that E. coli
O157:H7 is, indeed, the source of the inciting antigen, and,
if it is, minimize human contact with this pathogen.
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